Publications by authors named "Russell D Hull"

Claim this Profile
E
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.
Gerald Chi, Francesco Violi, Pasquale Pignatelli, Annarita Vestri, Alessandra Spagnoli, Russell D Hull

J Thromb Thrombolysis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
Arzu Kalayci, C Michael Gibson, Adrian F Hernandez, Russell D Hull, Alexander T Cohen

Thromb Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.
Anne-Céline Martin, Wei Huang, Samuel Z Goldhaber, Russell D Hull, Adrian F Hernandez

Clin Appl Thromb Hemost· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning to predict venous thrombosis in acutely ill medical patients.
Tarek Nafee, C Michael Gibson, Ryan Travis, Megan K Yee, Mathieu Kerneis, Russell D Hull

Res Pract Thromb Haemost· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.
Walter Ageno, Renato D Lopes, Megan K Yee, Adrian Hernandez, Russell D Hull

J Thromb Haemost· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
Gerald Chi, C Michael Gibson, Arzu Kalayci, Alexander T Cohen, Adrian F Hernandez, Russell D Hull

Intensive Care Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.
Megan K Yee, C Michael Gibson, Tarek Nafee, Mathieu Kerneis, Yazan Daaboul, Russell D Hull

TH Open· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
Tarek Nafee, C Michael Gibson, Megan K Yee, Mathieu Kerneis, Yazan Daaboul, Russell D Hull

Circulation· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.
Gerald Chi, C Michael Gibson, Yuyin Liu, Adrian F Hernandez, Russell D Hull

Am J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial.
Arzu Kalayci, C Michael Gibson, Gerald Chi, Megan K Yee, Serge Korjian, Russell D Hull

Thromb Haemost· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
Gerald Chi, C Michael Gibson, Adrian F Hernandez, Russell D Hull, Syed Hassan A Kazmi

Am J Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.
Megan K Yee, Tarek Nafee, Yazan Daaboul, Serge Korjian, Fahad AlKhalfan, Russell D Hull

J Thromb Thrombolysis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).
Gerald Chi, Megan K Yee, Alpesh N Amin, Samuel Z Goldhaber, Adrian F Hernandez, Russell D Hull

Circulation· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial.
Gerald Chi, Samuel Z Goldhaber, Russell D Hull, Adrian F Hernandez, Mathieu Kerneis

Thromb Haemost· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
Douglas F Arbetter, Purva Jain, Megan K Yee, Nathan Michalak, Adrian F Hernandez, Russell D Hull

Pharm Stat· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.
Gerald Chi, James L Januzzi, Serge Korjian, Yazan Daaboul, Samuel Z Goldhaber, Russell D Hull

J Thromb Thrombolysis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification.
C Michael Gibson, Alex C Spyropoulos, Alexander T Cohen, Russell D Hull, Samuel Z Goldhaber

TH Open· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
Alexander T Cohen, Robert A Harrington, Samuel Z Goldhaber, Russell D Hull, Brian L Wiens

N Engl J Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.
Serge Korjian, Yazan Daaboul, Rim Halaby, Samuel Z Goldhaber, Alexander T Cohen, Russell D Hull

J Cardiovasc Pharmacol Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease.
Danielle A Southern, Jasmine Poole, Alka Patel, Nigel Waters, Louise Pilote, Russell D Hull

Open Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants.
Russell D Hull, Meryl H Gersh

Curr Med Res Opin· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors.
Russell D Hull, Tazmin Merali, Allan Mills, Abigail L Stevenson, Jane Liang

Clin Appl Thromb Hemost· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery. A systematic review.
Russell D Hull, Jane Liang, David Bergqvist, Roger D Yusen

Thromb Haemost· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial.
Roger D Yusen, Russell D Hull, Sebastian M Schellong, Victor F Tapson, Manuel Monreal

Thromb Haemost· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence.
Russell D Hull, Grace Townshend

Thromb Haemost· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis